Brief: A1M Pharma able to finalize application to initiate clinical studies

Disruptive Pharma AB (publ)

14/11/2017 07:30

Nov 14 (Reuters) - A1M PHARMA AB  A1M.ST : 
    * A1M PHARMA REPORTS POSITIVE RESULTS FROM ITS GLP 
TOXICOLOGY 
STUDY - NOW ABLE TO FINALIZE APPLICATION TO INITIATE CLINICAL 
STUDIES 
 
Source text for Eikon:  ID:nBQN1wckqN  
Further company coverage:  A1M.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))